WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006014958) PLATELET ACTIVATION MARKERS AS PREDICTORS OF DISEASE AND OF RESPONSE TO THERAPY AND FOR MONITORING THERAPEUTIC PROGRESS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/014958    International Application No.:    PCT/US2005/026496
Publication Date: 09.02.2006 International Filing Date: 26.07.2005
IPC:
A61K 35/14 (2006.01), C12Q 1/56 (2006.01), G01N 33/53 (2006.01), G01N 33/86 (2006.01)
Applicants: BAYER HEALTHCARE LLC [US/US]; 511 Benedict Avenue, Tarrytown, NY 10591-5097 (US) (For All Designated States Except US).
CHAPMAN-MONTGOMERY, Sabrinah, E. [US/US]; (US) (For US Only).
OKRONGLY, David [US/US]; (US) (For US Only).
AHNADI, Charaf, E. [--/CA]; (CA) (For US Only).
WU, Alan [US/US]; (For US Only).
GERVAIS, Andre [--/CA]; (CA) (For US Only)
Inventors: CHAPMAN-MONTGOMERY, Sabrinah, E.; (US).
OKRONGLY, David; (US).
AHNADI, Charaf, E.; (CA).
WU, Alan; .
GERVAIS, Andre; (CA)
Agent: ELDERKIN, Dianne, B.; Woodcock Washburn LLP, 2929 Arch Street - Suite 1200, Philadelphia, PA 19104-2891 (US)
Priority Data:
60/591,025 26.07.2004 US
60/603,594 23.08.2004 US
Title (EN) PLATELET ACTIVATION MARKERS AS PREDICTORS OF DISEASE AND OF RESPONSE TO THERAPY AND FOR MONITORING THERAPEUTIC PROGRESS
(FR) MARQUEURS D'ACTIVATION DE PLAQUETTES UTILISES COMME PREDICTEURS DE MALADIE ET DE REPONSE A UN TRAITEMENT ET PERMETTANT DE SURVEILLER UNE EVOLUTION THERAPEUTIQUE
Abstract: front page image
(EN)Methods for assessing patient risk for platelet-affected disease states are disclosed. Also disclosed are methods for predicting the appropriateness of platelet antagonist therapy, and for monitoring patients during therapeutic intervention or during a combined regimen of therapy and angioplasty.
(FR)L'invention concerne des procédés permettant d'évaluer le risque pour un patient d'être atteint d'états pathologiques affectant les plaquettes. L'invention concerne également des procédés permettant de prévoir la pertinence d'un traitement antagoniste des plaquettes et de surveiller des patients pendant l'intervention thérapeutique ou pendant un régime combiné de traitement et d'angioplastie.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)